Risk From Pharma Reps Using Unapproved Content and Messaging in the Field Persists, but a Focus on Training Could Be the Answer
February 23, 2023 09:00 ET | ACTO
TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ACTO, the #1 Learning Platform in Life Sciences, today announced the results of a new study that explored the prevalence and impact of the use of...
ACTO Recognized as “Life Sciences Commercial Analytics and AI Trailblazer” by Everest Group
October 26, 2022 09:08 ET | ACTO
TORONTO, Oct. 26, 2022 (GLOBE NEWSWIRE) -- ACTO, the #1 learning platform in Life Sciences, has been recognized as a Trailblazer in Life Sciences Commercial Analytics and Artificial Intelligence...
ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences
July 07, 2022 05:00 ET | ACTO
TORONTO, July 07, 2022 (GLOBE NEWSWIRE) -- ACTO, the omnichannel learning and enablement platform for life sciences, today announced the closing of a US$18 million equity financing. The investment...
ACTO launches LAICA™, the first AI-powered conversational assistant for Life Sciences learning
June 15, 2022 08:00 ET | ACTO
TORONTO, June 15, 2022 (GLOBE NEWSWIRE) -- ACTO, the only complete commercial learning platform for the Life Science industry, announced the launch of "LAICA™", an artificial intelligence...
ACTO Bolsters Executive Management Team to Meet Significant US Commercial Growth
May 26, 2022 08:00 ET | ACTO
TORONTO, May 26, 2022 (GLOBE NEWSWIRE) -- ACTO, the only complete commercial learning platform for the life science industry, is strengthening its executive management team with two key additions to...